IGY Life Sciences Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$9.9M
- Investors
-
1
IGY Life Sciences General Information
Description
Developer of specific antibodies designed for the treatment of infectious and non-communicable diseases. The company's antibodies aim to strengthen and supplement the natural immune system against bacterial, viral, and autoimmune ailments, enabling humans and animals to live healthy lives.
Contact Information
Website
www.igylifesciences.comCorporate Office
- 34 Cumberland Street North
- Suite 201
- Thunder Bay, Ontario P7A 4L3
- Canada
Corporate Office
- 34 Cumberland Street North
- Suite 201
- Thunder Bay, Ontario P7A 4L3
- Canada
IGY Life Sciences Timeline
IGY Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 25-Jul-2022 | $9.9M | Completed | Generating Revenue | ||
| 4. Secondary Transaction - Private | 01-Jul-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 01-Mar-2016 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Mar-2015 | $25M | $25.1M | Completed | Startup | |
| 1. Angel (individual) | 17-Feb-2012 | $65.1K | $65.1K | Completed | Startup |
IGY Life Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
IGY Life Sciences Patents
IGY Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3214456-A1 | Vaccines and immunoglobulins targeting african swine fever virus, methods of preparing same, and methods of using same | Pending | 22-Mar-2021 | ||
| US-20240181032-A1 | Vaccines and immunoglobulins targeting african swine fever virus, methods of preparing same, and methods of using same | Pending | 22-Mar-2021 | ||
| US-20110015374-A1 | Method for commercial isolation of egg yolk igy, its product, and uses of the product | Inactive | 16-Jul-2009 | ||
| US-20080268124-A1 | Long shelf life; mayonnaise | Active | 30-Apr-2007 | ||
| US-7851008-B2 | Long shelf life; mayonnaise | Active | 30-Apr-2007 | A21D2/262 |
IGY Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
IGY Life Sciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Farm Credit Canada | Lender/Debt Provider | Minority |
IGY Life Sciences FAQs
-
When was IGY Life Sciences founded?
IGY Life Sciences was founded in 2009.
-
Where is IGY Life Sciences headquartered?
IGY Life Sciences is headquartered in Thunder Bay, Canada.
-
What is the size of IGY Life Sciences?
IGY Life Sciences has 19 total employees.
-
What industry is IGY Life Sciences in?
IGY Life Sciences’s primary industry is Drug Discovery.
-
Is IGY Life Sciences a private or public company?
IGY Life Sciences is a Private company.
-
What is IGY Life Sciences’s current revenue?
The current revenue for IGY Life Sciences is .
-
How much funding has IGY Life Sciences raised over time?
IGY Life Sciences has raised $35M.
-
Who are IGY Life Sciences’s investors?
Farm Credit Canada has invested in IGY Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
